Identification of a therapeutic compound for a genetic form of autism spectrum disorders thanks to high throughput screening


A team of researchers has highlighted the therapeutic potential of lithium in a patient with a rare form of autism spectrum disorder associated with SHANK3 gene mutation. This molecule, usually used to treat bipolar disorder, was identified thanks to high throughput screening of chemical compounds on human neurons derived from pluripotent stem cells, including those of the treated patient.

Back to top